Ray johnson

Talented ray johnson words... super

You have to be careful when you're choosing new vaccines to make sure that that is actually representative of what is circulating. Maybe for Delta that is easier, but right now it doesn't look like it's necessary. The question about the universal vaccines is super-interesting.

We have done a lot of work for flu and there are clear targets for influenza virus that can lead to broad protection the stalk ray johnson, partially the neuraminidase to the ectodomain of the ion channel, and so on and so forth. For SARS-CoV-2, it's not clear yet. There are some antibodies against ray johnson S2 ray johnson of the spike, which is more conserved, that are neutralizing antibodies but they are not very strong.

That doesn't mean that Tecartus (Brexucabtagene Autoleucel Suspension)- FDA vaccine based on that subunit won't work. We'll have to see about that. But there are now a lot of ray johnson that are pushing toward a universal coronavirus vaccine. But as you said, we have to also be careful what ray johnson talking about and how we define ray johnson. Some people, when they talk about the universal coronavirus vaccine, they mean something that would work against all the SARS-CoV-2 variants.

That's easier to do than a vaccine that protects against all betacoronaviruses. But I think even that is worth trying. We have to keep in mind expectations vs reality typical pipeline ray johnson for vaccine development, despite how quickly these SARS-CoV-2 vaccines were developed.

In addition, for a universal ray johnson vaccine, a substantial amount of time would be needed ray johnson design it and find targets and so on. I think it's possible to make a vaccine for all the SARS-like viruses.

It's possible to make a vaccine against all the SARS-CoV-2 variants, and it might be possible to make a betacoronavirus vaccine. It might even be possible ray johnson make a broader one, but it will take a lot of time. Verghese: I can't let you go without ray johnson asking you about Nipah virus, because it's happening in Kerala, Ipratropium Bromide and Albuterol Sulfate (Duoneb)- Multum my parents are from.

They're struggling with that outbreak and with SARS. Any closing thoughts on the Nipah virus. Krammer: I give a lecture on emerging viruses and the two examples that I usually talked about before the epidemic that I found scary were SARS coronavirus and Nipah ray johnson. That was one of the ray johnson why I jumped onto SARS-CoV-2 research so quickly, because I was actually scared ray johnson that virus.

But the other virus that I find problematic is Claim, ray johnson a number of reasons.

We have seen Nipah virus outbreaks in Bangladesh where there was human-to-human transmission and where it had a respiratory phenotype. I have no doubt that ray johnson current outbreak in India will be brought under control. But I think it will be good in the future to have a Nipah virus vaccine ready for use if we need it so that like with Ebola, if there is an outbreak and we see human-to-human transmission, we can vaccinate really quickly.

Nipah is a virus that has a ray johnson of potential, ray johnson with that case fatality rate, it's one ray johnson my nightmares. Topol: Florian, we really appreciate this conversation with you. There's no question this virus has humbled us. We have many mysteries still out ray johnson, whether it's the hair loss interpretation of breakthroughs, or why, in certain countries, the Delta variant behaves so differently from others, or why it goes down rapidly ray johnson goes back up.

There's so much we don't sanofi adr sny know, and we fitness good continue to turn to you for guidance. And we encourage everyone who's listening to us to realize that you're a great resource.

Thanks so much for being with us, and we'll stay tuned for your very helpful interpretations throughout the pandemic. Topol, MD, is one of the top 10 most cited researchers in medicine and frequently medsafe about technology in healthcare, including in his latest book, Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again.

Abraham Verghese, MD, is a critically acclaimed best-selling author and a physician with an international reputation for his focus on healing in an era when technology often overwhelms the human side of medicine. Florian Krammer, PhD, graduated from the University of Natural Resources and Ray johnson Sciences, Vienna, in 2010. He currently holds a position as a professor of vaccinology in the Department of Microbiology at the Icahn School of Medicine at Mount Sinai.

Cite this: Eric J. Topol, Abraham Verghese, Florian Krammer.



02.01.2020 in 23:56 Nilmaran:
It agree, very useful message

05.01.2020 in 10:00 Mazushakar:
Between us speaking, it is obvious. I suggest you to try to look in google.com

06.01.2020 in 13:58 Zugor:
Yes, I with you definitely agree